Stability of human atrial natriuretic peptide in blood samples. 1994

T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
Research and Development Laboratories, Diagnostic Science Department, Shionogi & Co., Ltd., Osaka, Japan.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008297 Male Males
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D005615 Freezing Liquids transforming into solids by the removal of heat. Melting
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013048 Specimen Handling Procedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation. Specimen Collection,Collection, Specimen,Collections, Specimen,Handling, Specimen,Handlings, Specimen,Specimen Collections,Specimen Handlings
D015592 Immunoradiometric Assay Form of radioimmunoassay in which excess specific labeled antibody is added directly to the test antigen being measured. Assay, Immunoradiometric,Assays, Immunoradiometric,Immunoradiometric Assays

Related Publications

T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
July 1999, Clinica chimica acta; international journal of clinical chemistry,
T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
October 2008, Clinical biochemistry,
T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
December 1991, Clinica chimica acta; international journal of clinical chemistry,
T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
June 1989, Revista espanola de fisiologia,
T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
October 1993, Circulation,
T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
April 1993, Circulation,
T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
May 1987, Japanese journal of medicine,
T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
May 1987, Clinical endocrinology,
T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
T Tsuji, and H Masuda, and K Imagawa, and M Haraikawa, and K Shibata, and M Kono, and K Inouye, and K Uchida
May 1994, Circulation,
Copied contents to your clipboard!